Mount Sinai Tisch Cancer Center

Leader in cancer prevention, detection, treatment & research. @IcahnMountSinai & @MountSinaiNYC
Appointments: 1-844-MD CANCER

[Mount Sinai Tisch Cancer Center @TischCancer]

We look forward to hearing from Anil Rustgi, MD, @columbiacancer on June 9.
"Molecular Regulation of Colon Cancer Pathogenesis"
Hosted by Ramon Parsons, MD, PhD @IcahnMountSinai

[Mount Sinai Tisch Cancer Center @TischCancer]

Could COVID Increase Your Risk for HPV-Related Cancers? https://t.co/7icaQvFJLj via @thisisflowspace
Dr. Stephanie Blank @IcahnMountSinai weighs in.

[Mount Sinai Tisch Cancer Center @TischCancer]

John Mascarenhas, MD, discusses key data from the SENTRY trial of selinexor plus ruxolitinib in JAK inhibitor–naïve myelofibrosis.
https://t.co/79jrqtOJxj

[Joshua Richter, MD, FACP @JoshuaRichterMD]

An extremely eloquent and brave man spoke at our survivors event. The sentence he wrote everyday during CART was “ today is a good day”. He went on to say this was either meant to be an affirmation or an aspiration each day ! Always focus on the patients @TischCancer #mmsm

[Mount Sinai Tisch Cancer Center @TischCancer]

https://t.co/5KXs9fUXyN
Deirdre Cohen, MD, @IcahnMountSinai, notes increased interest from patients with advanced #PancreaticCancer.

[Mount Sinai Tisch Cancer Center @TischCancer]

A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China https://t.co/USYlnT14Oh
@DDoroshow weighs in.

[Mount Sinai Tisch Cancer Center @TischCancer]

Jenn Pouliot, MSN, RN, OCN, discusses in @OncNursingNews cross-departmental hazardous drug handling protocols, 2-clinician verification mandates, and the critical role of APPs in procedural oncology settings.
https://t.co/FGoKWdeEHu
@MountSinaiNYC

[Mount Sinai Tisch Cancer Center @TischCancer]

New study in @NatureCancer shows focused irradiation helps immune cells keep cancer-fighting CAR T cells active and contained inside tumors.
https://t.co/1uoyb8nbAk
@MiriamMerad @Jalal_Ahmed @IcahnMountSinai

[Mount Sinai Tisch Cancer Center @TischCancer]

https://t.co/M6WzImwL1W
"The Phase 3 SENTRY results represent a meaningful advance for patients with myelofibrosis and underscore the promise of combining selinexor with ruxolitinib," said John Mascarenhas, MD, @IcahnMountSinai
#ASCO26

[Mount Sinai Tisch Cancer Center @TischCancer]

John Mascarenhas, MD, presents today at #ASCDO26:
Updated protocol: IMPROVEMF, a phase 1b trial of imetelstat (IME)+ ruxolitinib (RUX) in patients (pts) with intermediate (INT)-1/2 or high-risk (HR) myelofibrosis (MF)
https://t.co/UHoLItpCHA
@IcahnMountSinai

[Mount Sinai Tisch Cancer Center @TischCancer]

Poster presentation today at #ASCO26, from @JoshuaRichterMD and colleagues:
Comparative efficacy of belantamab mafodotin plus bortezomib and dexamethasone (BVd) vs standard of care in patients with relapsed/refractory #multiplemyeloma
https://t.co/gfmJeCDBqY

[Icahn School of Medicine at Mount Sinai @IcahnMountSinai]

Our researchers and clinicians at @TischCancer are excited to present new research at #ASCO26 across multiple #cancer specialties, including hematologic malignancies, thoracic oncology, urothelial cancer, gynecologic oncology, translational science, and cancer care delivery.

See the presentations: https://t.co/mfDreZhaQL

#CancerX #Cancer #Research @ASCO

[Mount Sinai Tisch Cancer Center @TischCancer]

Bridging Gaps in Multiple Myeloma Care: Donna Catamero, ANP-BC, OCN, CCRC Shares Insights From Interactive Workshop Series on Academic and Community Perspectives https://t.co/403LQZzKF9
@domenica76 #MultipleMyeloma

[Mount Sinai Tisch Cancer Center @TischCancer]

Congratulations to Ashutosh Tewari, @AshTewariMD, Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow.
@MountsinaiUro @IcahnMountSinai #prostatecancer

[Royal College of Physicians & Surgeons of Glasgow @rcpsglasgow]

“To be recognised by this great College, in this great city, is a privilege I will carry for the rest of my life.” World-leading surgeon, Professor Ashutosh Tewari speaking after he was made an Honorary Fellow of our College earlier this month. Read more: https://t.co/KyPJRuadpW

[Mount Sinai Tisch Cancer Center @TischCancer]

Jane Yoo, MD, says delayed diagnosis is one of the most urgent issues facing dermatology care for patients with skin of color.
https://t.co/Ku7OpQw5qo
#skincancer #melanoma @MSHSDerm @IcahnMountSinai

[OncLive.com @OncLive]

💥Previewing #EHA2026, cancer vaccines in multiple myeloma and... the best dad jokes💥

👀Yep, that's right, @JoshuaRichterMD of @TischCancer covered it all in our most recent #AskMeAnything‼️

🚨Go check it out🚨

#mmsm #oncology #OncLiveAMA #cancer #cancercare #myeloma #health

[nature @Nature]

Globally, lung cancer kills more people than breast, prostate and blood cancers combined, but now researchers think that they might have developed a pill that prevents it.

https://t.co/Nab9Q2MG4k

[Mount Sinai Tisch Cancer Center @TischCancer]

Could a pill prevent the world’s deadliest cancer? https://t.co/1fn3r2Hw5S via @YouTube
With Thomas Marron, MD, PhD, and Miriam Merad, MD, PhD, @MiriamMerad

[Mount Sinai Tisch Cancer Center @TischCancer]

We look forward to hearing from Karuna Ganesh, MD, PhD, on cancer plasticity.
@KarunaMDPhD
Hosted by @BadoIgor @IcahnMountSinai

[Mount Sinai Tisch Cancer Center @TischCancer]

We will be at #ASCO26, with presentations across multiple cancer specialties and cancer care delivery.
https://t.co/IaGzGRRPu0
@IcahnMountSinai